DIGITALDX
  • People
    • TEAM >
      • Michele Colucci
      • Eric Weiss
      • Anula Jayasuriya
      • Vanessa Small
      • David Kirk
      • Melody Po
      • Sharad Mishra
      • Maureen Downey
      • Valerie Kozak
      • Vivian Lu
    • EIR >
      • Jerry Lanchbury
      • Debbie Lin
      • Gisela Paulsen
      • Michael Doherty
      • Laura Yecies
      • Laura Mezey
      • Ramin Khaksar
      • Anita Samarth
      • L. Jasmine Kim
      • Swami Raote
    • Advisors >
      • Deborah DiSanzo
      • Russ Altman
      • Rebecca Maciera-Kaufman
      • Saul A. Fox
      • Girish Narayan
      • Maureen A. Spivack
      • Ferid Murad
      • Ronald Wyatt
    • Fellows >
      • Apply for Fellowship
  • Focus
    • About Us
    • Market Opportunity
    • Market Segmentation
  • Portfolio
    • Portfolio Companies
    • News
  • Impact
    • ESG + DEI
    • Gender Parity
  • Press
    • Press Releases
    • Events/Video
Picture
Anula Jayasuriya, MD, MBA
Picture
  • Founder + Managing Director, EXXClaim Capital
  • Co-Founder, Evolvence India Life Science Fund
  • Board of Trustees, Astia
  • Partner, Skline Ventures
  • VP Bus Dev, Genomics Collaborative
  • VP, Ganciclovir development, Roche
  • MBA, Harvard Business School
  • PhD, Molecular Genetics,  Harvard University
  • MD, Harvard Medical School
  • A.B., Biology, Harvard University
Anula Jayasuriya is a private equity executive and venture capitalist. She founded EXXclaim Capital, an early stage venture fund focused on catalyzing innovation, entrepreneurship and investment in Women’s Health. Anula co-founded the “Evolvence India Life Science Fund”, the first fund in India to focus on health care and invest in Indian pharmaceutical, biotechnology, medical device and contract services companies. She was a partner with Skyline Ventures in Palo Alto, and with the German/US venture capital firm TVM, in San Francisco. Her prior positions include VP Business Development at Genomics Collaborative Inc., and Vice President, Global Drug Development at Hoffman-La Roche for opportunistic infections in AIDS and Transplantation. Anula received a BA from Harvard, and an MD and PhD in Microbiology and Molecular Genetics from Harvard Medical School and an MBA from Harvard Business School, as well as a M. Phil. in pharmacology from the University of Cambridge, in England.
Disclaimer
Terms & Conditions
Privacy Policy
Investment Inquiries
Contact
Picture
Picture
Picture
 Copyright © 2022 All Rights Reserved
  • People
    • TEAM >
      • Michele Colucci
      • Eric Weiss
      • Anula Jayasuriya
      • Vanessa Small
      • David Kirk
      • Melody Po
      • Sharad Mishra
      • Maureen Downey
      • Valerie Kozak
      • Vivian Lu
    • EIR >
      • Jerry Lanchbury
      • Debbie Lin
      • Gisela Paulsen
      • Michael Doherty
      • Laura Yecies
      • Laura Mezey
      • Ramin Khaksar
      • Anita Samarth
      • L. Jasmine Kim
      • Swami Raote
    • Advisors >
      • Deborah DiSanzo
      • Russ Altman
      • Rebecca Maciera-Kaufman
      • Saul A. Fox
      • Girish Narayan
      • Maureen A. Spivack
      • Ferid Murad
      • Ronald Wyatt
    • Fellows >
      • Apply for Fellowship
  • Focus
    • About Us
    • Market Opportunity
    • Market Segmentation
  • Portfolio
    • Portfolio Companies
    • News
  • Impact
    • ESG + DEI
    • Gender Parity
  • Press
    • Press Releases
    • Events/Video